BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Newron Pharmaceuticals 

Via R. Lepetit
21040
Gerenzano      Italy
Phone: 39-02-9668131 Fax: 39-02-96681333


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Newron Pharmaceuticals (NWRN) Release: Xadago (Safinamide) New Drug Application (NDA) Accepted For Filing By The FDA 3/2/2015 11:18:52 AM
Newron Pharmaceuticals (NWRN) To Present At The 17th Annual BIO CEO & Investor Conference And The Leerink Global Healthcare Conference 2/6/2015 12:00:35 PM
Newron Pharmaceuticals (NWRN) Initiates Phase 2 Study Of sNN0029 In Patients With Amyotrophic Lateral Sclerosis 1/16/2015 3:03:53 PM
Newron Pharmaceuticals (NWRN) Announces Results Of Phase I Study Of NW-3509 Phase II Study In Schizophrenia Patients Planned For Q2 2015 1/15/2015 8:55:25 AM
Newron Pharmaceuticals (NWRN) Initiates Phase 2 Study Of sNN0031 In Patients With Parkinson’s disease 1/14/2015 9:18:52 AM
Newron Pharmaceuticals (NWRN) Release: CHMP Recommends Approval Of Xadago™ (Safinamide) To Treat Parkinson's Disease In The EU 1/7/2015 8:33:41 AM
Newron Pharmaceuticals (NWRN) Release: Safinamide New Drug Application (NDA) Re-Submitted To The US FDA 12/29/2014 7:34:19 AM
Newron Pharmaceuticals (NWRN) Reports Half-Year Results 2014 9/16/2014 11:19:03 AM
Newron Pharmaceuticals (NWRN) Shares To Be Included In The SXI Life Sciences® And The SXI Bio+Medtech® Indices 7/11/2014 8:40:08 AM
Newron Pharmaceuticals (NWRN) Establishes U.S. Operations 7/8/2014 9:03:09 AM
123456789